Click for best price
Oral Hypoglycemic Drugs Market Size, Share 2023
The global Oral Hypoglycemic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Oral Hypoglycemic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Hypoglycemic Drugs. This report contains market size and forecasts of Oral Hypoglycemic Drugs in global, including the following market information:
- Global Oral Hypoglycemic Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Oral Hypoglycemic Drugs Market Sales, 2018-2023, 2024-2032, (K Units)
- Global top five Oral Hypoglycemic Drugs companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Sulfonylureas (SU) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral Hypoglycemic Drugs include Pfizer, AstraZeneca, Johnson & Johnson, GlaxoSmithKline, Merck & Co, Eli Lilly, Sanofi, Takeda Pharmaceuticals and Novo Nordisk, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Hypoglycemic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Hypoglycemic Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Oral Hypoglycemic Drugs Market Segment Percentages, by Type, 2022 (%)
- Sulfonylureas (SU)
- Double Guanidine
- Glucosidase Inhibitor
- Insulin Synergist
Global Oral Hypoglycemic Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Oral Hypoglycemic Drugs Market Segment Percentages, by Application, 2022 (%)
Global Oral Hypoglycemic Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Oral Hypoglycemic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Oral Hypoglycemic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Oral Hypoglycemic Drugs revenues share in global market, 2022 (%)
- Key companies Oral Hypoglycemic Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Oral Hypoglycemic Drugs sales share in global market, 2022 (%)
key players include:
- Pfizer
- AstraZeneca
- Johnson & Johnson
- GlaxoSmithKline
- Merck & Co
- Eli Lilly
- Sanofi
- Takeda Pharmaceuticals
- Novo Nordisk
- Servier Laboratories
- Boehringer Ingelheim
- Bristol-Myers Squibb
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Hypoglycemic Drugs, market overview.
Chapter 2: Global Oral Hypoglycemic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Hypoglycemic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Hypoglycemic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Hypoglycemic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Oral Hypoglycemic Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
76 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oral Hypoglycemic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Hypoglycemic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Hypoglycemic Drugs Overall Market Size
2.1 Global Oral Hypoglycemic Drugs Market Size: 2022 VS 2032
2.2 Global Oral Hypoglycemic Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Oral Hypoglycemic Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Oral Hypoglycemic Drugs Players in Global Market
3.2 Top Global Oral Hypoglycemic Drugs Companies Ranked by Revenue
3.3 Global Oral Hypoglycemic Drugs Revenue by Companies
3.4 Global Oral Hypoglycemic Drugs Sales by Companies
3.5 Global Oral Hypoglycemic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oral Hypoglycemic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oral Hypoglycemic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Hypoglycemic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Oral Hypoglycemic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Hypoglycemic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Hypoglycemic Drugs Market Size Markets, 2022 & 2032
4.1.2 Sulfonylureas (SU)
4.1.3 Double Guanidine
4.1.4 Glucosidase Inhibitor
4.1.5 Insulin Synergist
4.2 By Type - Global Oral Hypoglycemic Drugs Revenue & Forecasts
4.2.1 By Type - Global Oral Hypoglycemic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Oral Hypoglycemic Drugs Revenue, 2024-2032
4.2.3 By Type - Global Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Oral Hypoglycemic Drugs Sales & Forecasts
4.3.1 By Type - Global Oral Hypoglycemic Drugs Sales, 2018-2023
4.3.2 By Type - Global Oral Hypoglycemic Drugs Sales, 2024-2032
4.3.3 By Type - Global Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Oral Hypoglycemic Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Hypoglycemic Drugs Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Oral Hypoglycemic Drugs Revenue & Forecasts
5.2.1 By Application - Global Oral Hypoglycemic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Oral Hypoglycemic Drugs Revenue, 2024-2032
5.2.3 By Application - Global Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Oral Hypoglycemic Drugs Sales & Forecasts
5.3.1 By Application - Global Oral Hypoglycemic Drugs Sales, 2018-2023
5.3.2 By Application - Global Oral Hypoglycemic Drugs Sales, 2024-2032
5.3.3 By Application - Global Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Oral Hypoglycemic Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Oral Hypoglycemic Drugs Market Size, 2022 & 2032
6.2 By Region - Global Oral Hypoglycemic Drugs Revenue & Forecasts
6.2.1 By Region - Global Oral Hypoglycemic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Oral Hypoglycemic Drugs Revenue, 2024-2032
6.2.3 By Region - Global Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Oral Hypoglycemic Drugs Sales & Forecasts
6.3.1 By Region - Global Oral Hypoglycemic Drugs Sales, 2018-2023
6.3.2 By Region - Global Oral Hypoglycemic Drugs Sales, 2024-2032
6.3.3 By Region - Global Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Oral Hypoglycemic Drugs Revenue, 2018-2032
6.4.2 By Country - North America Oral Hypoglycemic Drugs Sales, 2018-2032
6.4.3 US Oral Hypoglycemic Drugs Market Size, 2018-2032
6.4.4 Canada Oral Hypoglycemic Drugs Market Size, 2018-2032
6.4.5 Mexico Oral Hypoglycemic Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Oral Hypoglycemic Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Oral Hypoglycemic Drugs Sales, 2018-2032
6.5.3 Germany Oral Hypoglycemic Drugs Market Size, 2018-2032
6.5.4 France Oral Hypoglycemic Drugs Market Size, 2018-2032
6.5.5 U.K. Oral Hypoglycemic Drugs Market Size, 2018-2032
6.5.6 Italy Oral Hypoglycemic Drugs Market Size, 2018-2032
6.5.7 Russia Oral Hypoglycemic Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Oral Hypoglycemic Drugs Market Size, 2018-2032
6.5.9 Benelux Oral Hypoglycemic Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Oral Hypoglycemic Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Oral Hypoglycemic Drugs Sales, 2018-2032
6.6.3 China Oral Hypoglycemic Drugs Market Size, 2018-2032
6.6.4 Japan Oral Hypoglycemic Drugs Market Size, 2018-2032
6.6.5 South Korea Oral Hypoglycemic Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Oral Hypoglycemic Drugs Market Size, 2018-2032
6.6.7 India Oral Hypoglycemic Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Oral Hypoglycemic Drugs Revenue, 2018-2032
6.7.2 By Country - South America Oral Hypoglycemic Drugs Sales, 2018-2032
6.7.3 Brazil Oral Hypoglycemic Drugs Market Size, 2018-2032
6.7.4 Argentina Oral Hypoglycemic Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Hypoglycemic Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Oral Hypoglycemic Drugs Sales, 2018-2032
6.8.3 Turkey Oral Hypoglycemic Drugs Market Size, 2018-2032
6.8.4 Israel Oral Hypoglycemic Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Oral Hypoglycemic Drugs Market Size, 2018-2032
6.8.6 UAE Oral Hypoglycemic Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Oral Hypoglycemic Drugs Major Product Offerings
7.1.4 Pfizer Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Oral Hypoglycemic Drugs Major Product Offerings
7.2.4 AstraZeneca Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Oral Hypoglycemic Drugs Major Product Offerings
7.3.4 Johnson & Johnson Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Oral Hypoglycemic Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Merck & Co
7.5.1 Merck & Co Company Summary
7.5.2 Merck & Co Business Overview
7.5.3 Merck & Co Oral Hypoglycemic Drugs Major Product Offerings
7.5.4 Merck & Co Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck & Co Key News & Latest Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Company Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Oral Hypoglycemic Drugs Major Product Offerings
7.6.4 Eli Lilly Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Eli Lilly Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Oral Hypoglycemic Drugs Major Product Offerings
7.7.4 Sanofi Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Takeda Pharmaceuticals
7.8.1 Takeda Pharmaceuticals Company Summary
7.8.2 Takeda Pharmaceuticals Business Overview
7.8.3 Takeda Pharmaceuticals Oral Hypoglycemic Drugs Major Product Offerings
7.8.4 Takeda Pharmaceuticals Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Takeda Pharmaceuticals Key News & Latest Developments
7.9 Novo Nordisk
7.9.1 Novo Nordisk Company Summary
7.9.2 Novo Nordisk Business Overview
7.9.3 Novo Nordisk Oral Hypoglycemic Drugs Major Product Offerings
7.9.4 Novo Nordisk Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Novo Nordisk Key News & Latest Developments
7.10 Servier Laboratories
7.10.1 Servier Laboratories Company Summary
7.10.2 Servier Laboratories Business Overview
7.10.3 Servier Laboratories Oral Hypoglycemic Drugs Major Product Offerings
7.10.4 Servier Laboratories Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Servier Laboratories Key News & Latest Developments
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Company Summary
7.11.2 Boehringer Ingelheim Oral Hypoglycemic Drugs Business Overview
7.11.3 Boehringer Ingelheim Oral Hypoglycemic Drugs Major Product Offerings
7.11.4 Boehringer Ingelheim Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Boehringer Ingelheim Key News & Latest Developments
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Company Summary
7.12.2 Bristol-Myers Squibb Oral Hypoglycemic Drugs Business Overview
7.12.3 Bristol-Myers Squibb Oral Hypoglycemic Drugs Major Product Offerings
7.12.4 Bristol-Myers Squibb Oral Hypoglycemic Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Bristol-Myers Squibb Key News & Latest Developments
8 Global Oral Hypoglycemic Drugs Production Capacity, Analysis
8.1 Global Oral Hypoglycemic Drugs Production Capacity, 2018-2032
8.2 Oral Hypoglycemic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Hypoglycemic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Hypoglycemic Drugs Supply Chain Analysis
10.1 Oral Hypoglycemic Drugs Industry Value Chain
10.2 Oral Hypoglycemic Drugs Upstream Market
10.3 Oral Hypoglycemic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Hypoglycemic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Oral Hypoglycemic Drugs in Global Market
Table 2. Top Oral Hypoglycemic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Oral Hypoglycemic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Oral Hypoglycemic Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Oral Hypoglycemic Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Oral Hypoglycemic Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Oral Hypoglycemic Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Oral Hypoglycemic Drugs Product Type
Table 9. List of Global Tier 1 Oral Hypoglycemic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Hypoglycemic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Oral Hypoglycemic Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Oral Hypoglycemic Drugs Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Oral Hypoglycemic Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Oral Hypoglycemic Drugs Sales (K Units), 2024-2032
Table 16. By Application ? Global Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Oral Hypoglycemic Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Oral Hypoglycemic Drugs Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Oral Hypoglycemic Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Oral Hypoglycemic Drugs Sales (K Units), 2024-2032
Table 21. By Region ? Global Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Oral Hypoglycemic Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Oral Hypoglycemic Drugs Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Oral Hypoglycemic Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Oral Hypoglycemic Drugs Sales (K Units), 2024-2032
Table 26. By Country - North America Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Oral Hypoglycemic Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Oral Hypoglycemic Drugs Sales, (K Units), 2024-2032
Table 30. By Country - Europe Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Oral Hypoglycemic Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Oral Hypoglycemic Drugs Sales, (K Units), 2024-2032
Table 34. By Region - Asia Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Oral Hypoglycemic Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Oral Hypoglycemic Drugs Sales, (K Units), 2024-2032
Table 38. By Country - South America Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Oral Hypoglycemic Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Oral Hypoglycemic Drugs Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Oral Hypoglycemic Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Oral Hypoglycemic Drugs Sales, (K Units), 2024-2032
Table 46. Pfizer Company Summary
Table 47. Pfizer Oral Hypoglycemic Drugs Product Offerings
Table 48. Pfizer Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Oral Hypoglycemic Drugs Product Offerings
Table 52. AstraZeneca Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Oral Hypoglycemic Drugs Product Offerings
Table 56. Johnson & Johnson Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Oral Hypoglycemic Drugs Product Offerings
Table 60. GlaxoSmithKline Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Merck & Co Company Summary
Table 63. Merck & Co Oral Hypoglycemic Drugs Product Offerings
Table 64. Merck & Co Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Merck & Co Key News & Latest Developments
Table 66. Eli Lilly Company Summary
Table 67. Eli Lilly Oral Hypoglycemic Drugs Product Offerings
Table 68. Eli Lilly Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Eli Lilly Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Oral Hypoglycemic Drugs Product Offerings
Table 72. Sanofi Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Sanofi Key News & Latest Developments
Table 74. Takeda Pharmaceuticals Company Summary
Table 75. Takeda Pharmaceuticals Oral Hypoglycemic Drugs Product Offerings
Table 76. Takeda Pharmaceuticals Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Takeda Pharmaceuticals Key News & Latest Developments
Table 78. Novo Nordisk Company Summary
Table 79. Novo Nordisk Oral Hypoglycemic Drugs Product Offerings
Table 80. Novo Nordisk Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Novo Nordisk Key News & Latest Developments
Table 82. Servier Laboratories Company Summary
Table 83. Servier Laboratories Oral Hypoglycemic Drugs Product Offerings
Table 84. Servier Laboratories Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Servier Laboratories Key News & Latest Developments
Table 86. Boehringer Ingelheim Company Summary
Table 87. Boehringer Ingelheim Oral Hypoglycemic Drugs Product Offerings
Table 88. Boehringer Ingelheim Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Boehringer Ingelheim Key News & Latest Developments
Table 90. Bristol-Myers Squibb Company Summary
Table 91. Bristol-Myers Squibb Oral Hypoglycemic Drugs Product Offerings
Table 92. Bristol-Myers Squibb Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Bristol-Myers Squibb Key News & Latest Developments
Table 94. Oral Hypoglycemic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Oral Hypoglycemic Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Oral Hypoglycemic Drugs Production by Region, 2018-2023 (K Units)
Table 97. Global Oral Hypoglycemic Drugs Production by Region, 2024-2032 (K Units)
Table 98. Oral Hypoglycemic Drugs Market Opportunities & Trends in Global Market
Table 99. Oral Hypoglycemic Drugs Market Drivers in Global Market
Table 100. Oral Hypoglycemic Drugs Market Restraints in Global Market
Table 101. Oral Hypoglycemic Drugs Raw Materials
Table 102. Oral Hypoglycemic Drugs Raw Materials Suppliers in Global Market
Table 103. Typical Oral Hypoglycemic Drugs Downstream
Table 104. Oral Hypoglycemic Drugs Downstream Clients in Global Market
Table 105. Oral Hypoglycemic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral Hypoglycemic Drugs Segment by Type in 2022
Figure 2. Oral Hypoglycemic Drugs Segment by Application in 2022
Figure 3. Global Oral Hypoglycemic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral Hypoglycemic Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Oral Hypoglycemic Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. Oral Hypoglycemic Drugs Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oral Hypoglycemic Drugs Revenue in 2022
Figure 9. By Type - Global Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
Figure 11. By Type - Global Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
Figure 12. By Type - Global Oral Hypoglycemic Drugs Price (US$/Unit), 2018-2032
Figure 13. By Application - Global Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
Figure 15. By Application - Global Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
Figure 16. By Application - Global Oral Hypoglycemic Drugs Price (US$/Unit), 2018-2032
Figure 17. By Region - Global Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Oral Hypoglycemic Drugs Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
Figure 20. By Region - Global Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
Figure 21. By Country - North America Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
Figure 22. By Country - North America Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
Figure 23. US Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
Figure 28. Germany Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. France Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
Figure 37. China Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. India Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
Figure 43. By Country - South America Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
Figure 44. Brazil Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Oral Hypoglycemic Drugs Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Oral Hypoglycemic Drugs Sales Market Share, 2018-2032
Figure 48. Turkey Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Oral Hypoglycemic Drugs Revenue, (US$, Mn), 2018-2032
Figure 52. Global Oral Hypoglycemic Drugs Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Oral Hypoglycemic Drugs by Region, 2022 VS 2032
Figure 54. Oral Hypoglycemic Drugs Industry Value Chain
Figure 55. Marketing Channels
